Search

Monica A. Weingart

Examiner (ID: 2340)

Most Active Art Unit
2914
Art Unit(s)
2904, 2914, 2900, 2903, 2901
Total Applications
2416
Issued Applications
2384
Pending Applications
0
Abandoned Applications
32

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19067561 [patent_doc_number] => 20240101987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-28 [patent_title] => POLYPEPTIDE FUSIONS OR CONJUGATES FOR GENE EDITING [patent_app_type] => utility [patent_app_number] => 18/351747 [patent_app_country] => US [patent_app_date] => 2023-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25807 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18351747 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/351747
POLYPEPTIDE FUSIONS OR CONJUGATES FOR GENE EDITING Jul 12, 2023 Pending
Array ( [id] => 19096288 [patent_doc_number] => 20240115515 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => LIVER-SPECIFIC DRUG DELIVERY CARRIER COMPRISING NUCLEIC ACID NANOPARTICLE AND CHOLESTEROL AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/166782 [patent_app_country] => US [patent_app_date] => 2023-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13225 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18166782 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/166782
LIVER-SPECIFIC DRUG DELIVERY CARRIER COMPRISING NUCLEIC ACID NANOPARTICLE AND CHOLESTEROL AND USE THEREOF Feb 8, 2023 Pending
Array ( [id] => 18628570 [patent_doc_number] => 20230287441 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => PROGRAMMABLE INSERTION APPROACHES VIA REVERSE TRANSCRIPTASE RECRUITMENT [patent_app_type] => utility [patent_app_number] => 18/067214 [patent_app_country] => US [patent_app_date] => 2022-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16205 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18067214 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/067214
PROGRAMMABLE INSERTION APPROACHES VIA REVERSE TRANSCRIPTASE RECRUITMENT Dec 15, 2022 Pending
Array ( [id] => 18359972 [patent_doc_number] => 20230141563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-11 [patent_title] => METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IGM RESPONSES [patent_app_type] => utility [patent_app_number] => 17/964534 [patent_app_country] => US [patent_app_date] => 2022-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17964534 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/964534
METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IGM RESPONSES Oct 11, 2022 Abandoned
Array ( [id] => 18921534 [patent_doc_number] => 20240024538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => EPITHELIAL CELL TUBE FOR TRACHEAL TRANSPLANTATION [patent_app_type] => utility [patent_app_number] => 17/907837 [patent_app_country] => US [patent_app_date] => 2022-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4866 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17907837 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/907837
EPITHELIAL CELL TUBE FOR TRACHEAL TRANSPLANTATION Jun 16, 2022 Pending
Array ( [id] => 17836379 [patent_doc_number] => 20220273684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => Systems and Methods to Identify Pancreatic Ductal Adenocarcinoma and Uses Thereof [patent_app_type] => utility [patent_app_number] => 17/653114 [patent_app_country] => US [patent_app_date] => 2022-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12403 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653114 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/653114
Systems and Methods to Identify Pancreatic Ductal Adenocarcinoma and Uses Thereof Feb 28, 2022 Pending
Array ( [id] => 19156198 [patent_doc_number] => 20240148905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS [patent_app_type] => utility [patent_app_number] => 18/277858 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42136 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -55 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277858 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/277858
METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS Feb 17, 2022 Pending
Array ( [id] => 19049411 [patent_doc_number] => 20240091380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES [patent_app_type] => utility [patent_app_number] => 18/274499 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35454 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -35 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274499 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/274499
GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES Jan 30, 2022 Pending
Array ( [id] => 19098123 [patent_doc_number] => 20240117351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-11 [patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM [patent_app_type] => utility [patent_app_number] => 18/274826 [patent_app_country] => US [patent_app_date] => 2022-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51088 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -44 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274826 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/274826
COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM Jan 27, 2022 Pending
Array ( [id] => 18862317 [patent_doc_number] => 20230416753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => SIRNA FOR TREATING HEPATIC FIBROSIS AND DELIVERY PREPARATION THEREOF [patent_app_type] => utility [patent_app_number] => 18/037598 [patent_app_country] => US [patent_app_date] => 2021-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7257 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037598 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/037598
SIRNA FOR TREATING HEPATIC FIBROSIS AND DELIVERY PREPARATION THEREOF Nov 18, 2021 Pending
Array ( [id] => 18903008 [patent_doc_number] => 20240018493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-18 [patent_title] => KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION [patent_app_type] => utility [patent_app_number] => 18/251941 [patent_app_country] => US [patent_app_date] => 2021-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30316 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -100 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251941 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251941
KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION Nov 9, 2021 Pending
Array ( [id] => 20193838 [patent_doc_number] => 20250270548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING TARDBP ASSOCIATED DISEASES [patent_app_type] => utility [patent_app_number] => 18/039928 [patent_app_country] => US [patent_app_date] => 2021-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18132 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039928 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/039928
COMPOSITIONS AND METHODS FOR TREATING TARDBP ASSOCIATED DISEASES Nov 7, 2021 Pending
Array ( [id] => 18895539 [patent_doc_number] => 20240011024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => CRISPR SPACER TAGS FOR LABELING AND/OR IDENTIFYING BACTERIA, AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 18/251636 [patent_app_country] => US [patent_app_date] => 2021-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13716 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251636 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251636
CRISPR SPACER TAGS FOR LABELING AND/OR IDENTIFYING BACTERIA, AND METHODS OF USING THE SAME Nov 3, 2021 Pending
Array ( [id] => 18842636 [patent_doc_number] => 20230405040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS [patent_app_type] => utility [patent_app_number] => 18/035198 [patent_app_country] => US [patent_app_date] => 2021-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30408 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -144 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035198 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/035198
METHODS FOR TREATING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WITH LPA-TARGETED RNAi CONSTRUCTS Nov 3, 2021 Pending
Array ( [id] => 18282936 [patent_doc_number] => 20230098408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-30 [patent_title] => SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/449140 [patent_app_country] => US [patent_app_date] => 2021-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7616 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 272 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17449140 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/449140
SINGLE NUCLEIC ACID FOR REAL-TIME DETECTION FOR SNP ANALYSIS OF APOE GENE AND DETECTION METHOD USING THE SAME Sep 27, 2021 Abandoned
Array ( [id] => 17444199 [patent_doc_number] => 20220064704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-03 [patent_title] => METHODS OF PREPARING LARGE QUANTITIES OF SINGLE-STRANDED DNA (ssDNA) [patent_app_type] => utility [patent_app_number] => 17/410925 [patent_app_country] => US [patent_app_date] => 2021-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17232 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17410925 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/410925
METHODS OF PREPARING LARGE QUANTITIES OF SINGLE-STRANDED DNA (ssDNA) Aug 23, 2021 Abandoned
Array ( [id] => 17370385 [patent_doc_number] => 20220025437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTION [patent_app_type] => utility [patent_app_number] => 17/386451 [patent_app_country] => US [patent_app_date] => 2021-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8528 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386451 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/386451
NOVEL METHOD OF COMBINED MOLECULAR CLAMPING AND ALLELE SPECIFIC qPCR TECHNOLOGY FOR KRAS G12C MUTATION DETECTION Jul 26, 2021 Abandoned
Array ( [id] => 18565730 [patent_doc_number] => 20230256057 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-17 [patent_title] => TREATMENT OF IMMUNE DEPRESSION [patent_app_type] => utility [patent_app_number] => 18/015820 [patent_app_country] => US [patent_app_date] => 2021-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37162 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015820 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/015820
TREATMENT OF IMMUNE DEPRESSION Jul 12, 2021 Pending
Array ( [id] => 18537810 [patent_doc_number] => 20230242911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR [patent_app_type] => utility [patent_app_number] => 18/004877 [patent_app_country] => US [patent_app_date] => 2021-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10309 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18004877 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/004877
MicroRNA-TARGETED THERAPY FOR CARDIAC REPAIR Jul 8, 2021 Pending
Array ( [id] => 19641419 [patent_doc_number] => 20240415939 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-19 [patent_title] => COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/002767 [patent_app_country] => US [patent_app_date] => 2021-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23245 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18002767 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/002767
COMPOSITIONS FOR GENOME EDITING AND METHODS OF USE THEREOF Jun 29, 2021 Pending
Menu